Daniel Engelman1, Gavin R Wheaton2, Reapi L Mataika3, Joseph H Kado4, Samantha M Colquhoun5, Bo Remenyi6, Andrew C Steer1. 1. Department of Paediatrics, Centre for International Child Health, University of Melbourne, Melbourne, Victoria, Australia; Group A Streptococcal Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia; Department of General Medicine, Royal Children's Hospital, Melbourne, Victoria, Australia. 2. Department of Cardiology , Women's and Children's Hospital , Adelaide, South Australia , Australia. 3. Department of Paediatrics , Colonial War Memorial Hospital , Suva , Fiji. 4. Department of Paediatrics, Colonial War Memorial Hospital, Suva, Fiji; College of Medicine, Nursing and Health Sciences, Fiji National University, Suva, Fiji. 5. Department of Paediatrics, Centre for International Child Health, University of Melbourne, Melbourne, Victoria, Australia; Group A Streptococcal Research Group, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia. 6. Menzies School of Health Research , Darwin, Northern Territory , Australia.
Abstract
OBJECTIVES: Echocardiography is a sensitive test for rheumatic heart disease (RHD) screening; however the natural history of RHD detected on screening has not been established. We aimed to evaluate the progression of screening-detected RHD in Fiji. METHODS: All young people previously diagnosed with RHD through screening, with echocardiograms available for review, were eligible. All baseline echocardiograms were reported again. Participants underwent follow-up echocardiography. A paediatric cardiologist determined the diagnosis using the World Heart Federation criteria and assessed the severity of regurgitation and stenosis. RESULTS: Ninety-eight participants were recruited (mean age, 17 years; median duration of follow-up, 7.5 years). Two other children had died from severe RHD. Fourteen of 20 (70%) definite RHD cases persisted or progressed, including four (20%) requiring valve surgery. Four (20%) definite RHD cases improved to borderline RHD and two (10%) to normal. Four of 17 (24%) borderline cases progressed to definite RHD (moderate: 2; severe: 2) and two (12%) improved to normal. Four of the 55 cases reclassified as normal at baseline progressed to borderline RHD. Cases with a follow-up interval >5 years were more likely to improve (37% vs 6%, p=0.03). CONCLUSIONS: The natural history of screening-detected RHD is not benign. Most definite RHD cases persist and others may require surgery or succumb. Progression of borderline cases to severe RHD demonstrates the need for monitoring and individualised consideration of prophylaxis. Robust health system structures are needed for follow-up and delivery of secondary prophylaxis if RHD screening is to be scaled up.
OBJECTIVES: Echocardiography is a sensitive test for rheumatic heart disease (RHD) screening; however the natural history of RHD detected on screening has not been established. We aimed to evaluate the progression of screening-detected RHD in Fiji. METHODS: All young people previously diagnosed with RHD through screening, with echocardiograms available for review, were eligible. All baseline echocardiograms were reported again. Participants underwent follow-up echocardiography. A paediatric cardiologist determined the diagnosis using the World Heart Federation criteria and assessed the severity of regurgitation and stenosis. RESULTS: Ninety-eight participants were recruited (mean age, 17 years; median duration of follow-up, 7.5 years). Two other children had died from severe RHD. Fourteen of 20 (70%) definite RHD cases persisted or progressed, including four (20%) requiring valve surgery. Four (20%) definite RHD cases improved to borderline RHD and two (10%) to normal. Four of 17 (24%) borderline cases progressed to definite RHD (moderate: 2; severe: 2) and two (12%) improved to normal. Four of the 55 cases reclassified as normal at baseline progressed to borderline RHD. Cases with a follow-up interval >5 years were more likely to improve (37% vs 6%, p=0.03). CONCLUSIONS: The natural history of screening-detected RHD is not benign. Most definite RHD cases persist and others may require surgery or succumb. Progression of borderline cases to severe RHD demonstrates the need for monitoring and individualised consideration of prophylaxis. Robust health system structures are needed for follow-up and delivery of secondary prophylaxis if RHD screening is to be scaled up.
Authors: Helmut Baumgartner; Judy Hung; Javier Bermejo; John B Chambers; Arturo Evangelista; Brian P Griffin; Bernard Iung; Catherine M Otto; Patricia A Pellikka; Miguel Quiñones Journal: J Am Soc Echocardiogr Date: 2009-01 Impact factor: 5.251
Authors: Patrizio Lancellotti; Christophe Tribouilloy; Andreas Hagendorff; Luis Moura; Bogdan A Popescu; Eustachio Agricola; Jean-Luc Monin; Luc A Pierard; Luigi Badano; Jose L Zamorano Journal: Eur J Echocardiogr Date: 2010-04
Authors: Daniel Engelman; Reapi L Mataika; Joseph H Kado; Maureen Ah Kee; Susan Donath; Tom Parks; Andrew C Steer Journal: Trop Med Int Health Date: 2016-10-28 Impact factor: 2.622
Authors: Tom Parks; Joseph Kado; Anne E Miller; Brenton Ward; Rachel Heenan; Samantha M Colquhoun; Till W Bärnighausen; Mariana Mirabel; David E Bloom; Robin L Bailey; Isimeli N Tukana; Andrew C Steer Journal: PLoS Negl Trop Dis Date: 2015-09-15
Authors: Liesl Zühlke; Mark E Engel; Carolina E Lemmer; Marnie van de Wall; Simpiwe Nkepu; Alet Meiring; Michael Bestawros; Bongani M Mayosi Journal: BMC Cardiovasc Disord Date: 2016-02-19 Impact factor: 2.298
Authors: Emmy Okello; Zhang Wanzhu; Charles Musoke; Aliku Twalib; Barbara Kakande; Peter Lwabi; Nyakoojo B Wilson; Charles K Mondo; R Odoi-Adome; Juergen Freers Journal: Cardiovasc J Afr Date: 2013-04 Impact factor: 1.167
Authors: Scott Dougherty; Andrea Beaton; Bruno R Nascimento; Liesl J Zühlke; Maziar Khorsandi; Nigel Wilson Journal: Ann Pediatr Cardiol Date: 2018 Jan-Apr
Authors: Jean Jacques Noubiap; Valirie N Agbor; Jean Joel Bigna; Arnaud D Kaze; Ulrich Flore Nyaga; Bongani M Mayosi Journal: Sci Rep Date: 2019-11-19 Impact factor: 4.379